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Every year on our planet, 8.2 million people die of 
cancer.[1] That number equals the population of a 
whole country such as Rwanda, Austria or Haiti. By 
2050 it is estimated that the figure will more than 
double to approximately 17.5 million.[2] As personal 
incomes increase in the developing world, lifestyles evolve towards 
the pattern seen in high-income populations, with obesity, excessive 
alcohol consumption, air pollution and smoking, all of which increase 
the risk of cancer. Already around 60% of all new cancer cases and 
70% of related deaths occur in low- and middle-income countries.[1]
Globally, cancer kills more people than HIV/AIDS, tuberculosis 
and malaria.[2] In the hierarchy of causes of death, it occupies a place 
close to the top in most countries.
Is the cancer incidence in South Africa (SA) following the global 
trend? Anyone who consults the latest list of all underlying causes of 
death (in 2013) in our country, published by Statistics South Africa 
recently,[3] would be surprised to see that cancer does not appear 
among the ten most frequent causes. A cursory examination of the 
list may create the impression that SA enjoys the unique privilege of 
having been spared the increase in the incidence of malignant disease 
seen in the rest of the world.
For the more inquisitive mind, however, the joy would be short-
lived, as it would soon become clear that malignant disease has 
been reported according to its anatomical location: ‘malignant 
neoplasm of digestive organs’, ‘malignant neoplasm of respiratory 
and intrathoracic organs’, and so on. The reporting was based on 
the International Statistical Classification of Diseases and Related 
Health Problems (10th edition) (ICD-10).[4] As the ICD-10 does not 
provide for an all-encompassing ‘malignant diseases’ category, the 
total deaths from cancer are distributed over 15 anatomical sites, with 
the resulting smaller figures. Without disputing the epidemiological 
value of classifying malignant neoplasms by their anatomical location, 
when strategising for optimal healthcare delivery the total number 
of deaths from all these neoplasms would be required in order to 
understand the magnitude of the problem.
The total number of deaths from cancer in 2013, arrived at by 
adding together the numbers corresponding to various anatomical 
locations, was 36 726 (8% of all deaths). This figure reveals that 
malignant neoplasms were in fact the second most frequent cause 
of death in SA, second only to tuberculosis. Also, cancer killed 
more people than other non-communicable diseases such as 
cerebrovascular pathology, hypertension and diabetes. This sobering 
finding has far-reaching implications.
First of all, the second place of cancer in the hierarchy of causes 
of death will have to be acknowledged. At present it does not even 
appear on the list of the ten most frequent causes. Thereafter, 
adequate planning followed by effective measures will be needed 
in order to address the already considerable and steadily increasing 
threat of malignant disease. Likewise, the top national research 
priorities should reflect the need for cancer control.
In order to increase our resolve to implement such significant 
changes, we need to evaluate the economic impact of cancer on 
SA more precisely. At present the magnitude of this impact in the 
country is not known, but the figures may be considerable. In the 
USA, where almost 600 000 people die of cancer every year, the losses 
to the economy were estimated at USD216.6 billion in 2009. While 
the total healthcare costs were impressive at USD86.6 billion, the 
costs of lost productivity from premature deaths were even higher, 
amounting to USD130 billion.[5] Worldwide, it has been estimated 
that cancer has the highest economic impact, from premature death 
and disability, of all causes of death.[6] The total annual loss for the 
world economy was evaluated at USD1.16 trillion in 2010.[1]
A major contributor to the fight against the increased burden 
of malignant disease is the National Cancer Registry. Established 
in 1986 as a pathology-based registry, its activity was impaired by 
lack of funding and reluctance to communicate data on the part of 
numerous stakeholders such as private laboratories, among others, 
mainly out of fear of consequences arising from disclosure of 
information that could be regarded as private and confidential.[7] The 
registry was revitalised in 2009, with the intention of transforming 
it into a hospital-based and later a population-based one. Although 
the reporting of cases was made compulsory by law in 2011, its 
completeness still needs to be tested. There remains a long distance to 
be covered to establishing a population-based registry. Continuing to 
face challenges, the registry has not yet processed its backlog of data 
since 2008, nor has it issued a comprehensive report.
A co-ordinated, evidence-based national approach to prevent-
ing and treating cancer is necessary today more than ever before. 
This should be framed by a National Cancer Control Plan,[8] 
formu lated along the guidelines established by the World Health 
Organization.[9] The Cancer Association of South Africa under -
took to formulate a cancer control plan as early as 1993. Although 
the plan was supported by representatives of academia, national 
medical research organisations, provincial administrations, hospice 
organisations and non-governmental organisations, it was not 
adopted by the National Department of Health until 1999. The 
National Cancer Control Plan is currently being updated, and 
although the Department of Health faces many new challenges, 
such as antimicrobial resistance, rapid implementation is expected 
to address the scourge of cancer.
It has to be acknowledged that a number of policies aimed at 
limiting the risk of malignant disease in SA have been implemented 
in the past two decades. The Tobacco Products Control Act and 
the Liquor Act have sought to limit the use of these recognised 
carcinogenic products. The cervical cancer screening programme 
and more recently the vaccination programme against human 
papillomavirus (in its pilot phase at present) will contribute to 
reducing the incidence of cervical cancer.[10] Another significant 
measure was the establishing of the Ministerial Advisory Committee 
on Cancer in 2013. Further, the Department of Health’s Strategic Plan 
for 2014/15 - 2018/19[11] prioritises the fight against cancer of the 
cervix. The effectiveness of these measures needs to be evaluated by 
the National Cancer Registry.
In February 2014, the International Agency for Research on 
Cancer (IARC) launched the latest edition of a respected publication, 
the World Cancer Report 2014,[1] which deals with numerous facets 
of cancer epidemiology, prevention, treatment and research. The 
most salient conclusion of this report was, as defined by one of 
its editors, Dr Christopher Wild, Director of the IARC, that ‘we 
cannot treat our way out of the cancer problem’.[12] The costs of 
adequate treatments are progressively becoming unsustainable, even 
for high-income countries:[12] cancer control must therefore resort to 
concerted action against the main risk factors – tobacco use, obesity 
and lack of physical activity, excessive exposure to sunlight, radiation, 
infectious agents, and chemicals in food and in the environment. 
Such action would require adequate policies, proper implementation 
and sustained monitoring, all supported by a comprehensive National 
Cancer Control Plan.
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The SA Medical Research Council (MRC) is poised to support 
research aimed at reducing the cancer burden. To this purpose, it 
plans to support research that provides reliable and up-to-date figures 
on the burden of cancer in our country to augment the surveillance 
measures. The MRC will also promote research into the prevalence 
and geographical distribution of cancer to better understand risk 
factors, as well as funding research addressing effective ways of 
mitigating the effects of carcinogens. Through its Strategic Health 
Innovation Partnerships division, the MRC is already funding 
translational research into new medicines and devices for the 
prevention, diagnosis and management of cancer. Addressing 
malignant disease as one of the national health priorities, the MRC 
will fund dedicated cancer centres in SA under the leadership of 
prominent scientists, which will respond to the most pressing and 
relevant cancer research questions.
The time has arrived to acknowledge the impact of cancer on the 
SA population, at present as well as in future decades.
The data published by Stats SA clearly place malignant disease 
as the second most frequent cause of death in our country in 2013. 
Death from cancer may rise to first place once tuberculosis and HIV 
have been more efficiently controlled. To improve the health of South 
Africans, adequate attention to cancer is required, and should include 
a holistic approach that addresses research, effective management 
and prevention modalities.
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